MergerLinks Header Logo

Request Deal Involvement

An investment consortium completed the acquisition of Cellular Biomedicine Group for $384m.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

O'Melveny & Myers

legal advisors

O'Melveny & Myers

Kirkland & Ellis

legal advisors

Kirkland & Ellis

Morgan Lewis & Bockius

legal advisors

Morgan Lewis & Bockius

Jefferies & Company

financial advisors

Jefferies & Company

White & Case

legal advisors

White & Case

Gibson Dunn & Crutcher

legal advisors

Gibson Dunn & Crutcher

Covington & Burling

legal advisors to financial advisors

Covington & Burling

or

Principals

TONY BIZUO LIU

bidder

TONY BIZUO LIU

CELLULAR BIOMEDICINE GROUP

target

CELLULAR BIOMEDICINE GROUP

YIHONG YAO

bidder

YIHONG YAO

MISSION RIGHT LIMITED

bidder

MISSION RIGHT LIMITED

DANGDAI INTERNATIONAL GROUP

bidder

DANGDAI INTERNATIONAL GROUP

TF CAPITAL

bidder

TF CAPITAL

LI ZHANG

bidder

LI ZHANG

CHENGXAING DAI

bidder

CHENGXAING DAI

HILLHOUSE CAPITAL GROUP

bidder

HILLHOUSE CAPITAL GROUP

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - An investment consortium completed the acquisition of Cellular Biomedicine Group for $384m.